RI
ODT

RTW Investments’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

RTW Investments’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,000,139
Closed -$19.2M – 117
2020
Q4 		$19.2M Buy
1,000,139
+883
+0.1% +$13.6K 0.32% 59
2020
Q3 		$13.4M Buy
999,256
+518,229
+108% +$14.7M 0.32% 60
2020
Q2 		$20.4M Buy
481,027
+114,942
+31% +$3.72M 0.57% 39
2020
Q1 		$10.1M Buy
366,085
+9,333
+3% +$272K 0.44% 42
2019
Q4 		$11.6M Buy
356,752
+16,860
+5% +$523K 0.44% 44
2019
Q3 		$8.85M Buy
339,892
+736
+0.2% +$24.6K 0.53% 39
2019
Q2 		$12.4M Buy
339,156
+7,916
+2% +$190K 0.66% 33
2019
Q1 		$7.32M Buy
331,240
+19,450
+6% +$340K 0.5% 36
2018
Q4 		$4.39M Buy
311,790
+22,182
+8% +$345K 0.4% 36
2018
Q3 		$5.62M Buy
289,608
+13,240
+5% +$270K 0.34% 34
2018
Q2 		$6.1M Buy
276,368
+1,824
+0.7% +$42.5K 0.44% 29
2018
Q1 		$5.3M Sell
274,544
-23,011
-8% -$543K 0.5% 28
2017
Q4 		$6.77M Buy
+297,555
New +$7.03M 1.13% 24

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

RTW Investments's ODT Position: Q1 2021 in Review

RTW Investments sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 1,000,139 shares — an estimated $19.2M sold.

RTW Investments first reported a position in ODT in Q4 2017 and held it in 13 quarters. The position peaked at $20.4M in Q2 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

  • RTW Investments reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • RTW Investments sold 1,000,139 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $19.2M.
  • RTW Investments first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2017 and held it in 13 quarters.
  • RTW Investments's Odonate Therapeutics, Inc. Common Stock position peaked at $20.4M in Q2 2020.
  • 83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on RTW Investments's 13F filing for Q1 2021, filed 14 May 2021.